You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)
|
|---|---|
| Published in |
Journal of Infectious Diseases, November 2012
|
| DOI | 10.1093/infdis/jis670 |
| Pubmed ID | |
| Authors |
Lindsey R. Baden, Stephen R. Walsh, Michael S. Seaman, Robert P. Tucker, Kathleen H. Krause, Alka Patel, Jennifer A. Johnson, Jane Kleinjan, Katherine E. Yanosick, James Perry, Elise Zablowsky, Peter Abbink, Lauren Peter, M. Justin Iampietro, Ann Cheung, Maria G. Pau, Mo Weijtens, Jaap Goudsmit, Edith Swann, Mark Wolff, Hayley Loblein, Raphael Dolin, Dan H. Barouch |
| Abstract |
We report the first-in-human safety and immunogenicity assessment of a prototype Ad26 vector-based human immunodeficiency virus (HIV) vaccine in humans. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| United States | 1 | 1% |
| Unknown | 78 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 19% |
| Student > Bachelor | 12 | 15% |
| Student > Ph. D. Student | 10 | 13% |
| Other | 9 | 11% |
| Student > Master | 5 | 6% |
| Other | 6 | 8% |
| Unknown | 23 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 16 | 20% |
| Medicine and Dentistry | 13 | 16% |
| Immunology and Microbiology | 11 | 14% |
| Biochemistry, Genetics and Molecular Biology | 8 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
| Other | 5 | 6% |
| Unknown | 23 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2024.
All research outputs
#1,739,026
of 25,809,966 outputs
Outputs from Journal of Infectious Diseases
#1,281
of 14,932 outputs
Outputs of similar age
#11,408
of 204,030 outputs
Outputs of similar age from Journal of Infectious Diseases
#15
of 141 outputs
Altmetric has tracked 25,809,966 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 14,932 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.5. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,030 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.